Entry - #614431 - VENTRICULAR SEPTAL DEFECT 2; VSD2 - OMIM
# 614431

VENTRICULAR SEPTAL DEFECT 2; VSD2


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
6q24.1 Ventricular septal defect 2 614431 AD 3 CITED2 602937
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
CARDIOVASCULAR
Heart
- Ventricular septal defect, perimembranous
MOLECULAR BASIS
- Caused by mutation in the CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2 gene (CITED2, 602937.0001)
Ventricular septal defect - PS614429 - 3 Entries

TEXT

A number sign (#) is used with this entry because of evidence that ventricular septal defect-2 (VSD2) can be caused by heterozygous mutation in the CITED2 gene (602937) on chromosome 6q24.


Description

Ventricular septal defect (VSD) is the most common form of congenital cardiovascular anomaly, occurring in nearly 50% of all infants with a congenital heart defect and accounting for 14% to 16% of cardiac defects that require invasive treatment within the first year of life. Congenital VSDs may occur alone or in combination with other cardiac malformations. Large VSDs that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death (summary by Wang et al. (2011, 2011)).

For a discussion of genetic heterogeneity of ventricular septal defect, see VSD1 (614429).


Molecular Genetics

Sperling et al. (2005) screened a cohort of 392 patients with congenital heart defects for mutations in the CITED2 gene (602937) and identified a 27-bp deletion in a patient with a perimembranous ventricular septal defect. The mutation, which was not found in 192 controls, resulted in significant loss of HIF1A (603348) transcriptional repressive capacity and significantly diminished TFAP2C (601602) coactivation.


REFERENCES

  1. Sperling, S., Grimm, C. H., Dunkel, I., Mebus, S., Sperling, H.-P., Ebner, A., Galli, R., Lehrach, H., Fusch, C., Berger, F., Hammer, S. Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum. Mutat. 26: 575-582, 2005. [PubMed: 16287139, related citations] [Full Text]

  2. Wang, J., Fang, M., Liu, X.-Y., Xin, Y.-F., Liu, Z.-M., Chen, X.-Z., Wang, X.-Z., Fang, W.-Y., Liu, X., Yang, Y.-Q. A novel GATA4 mutation responsible for congenital ventricular septal defects. Int. J. Molec. Med.. 28: 557-564, 2011. [PubMed: 21637914, related citations] [Full Text]

  3. Wang, J., Xin, Y.-F., Liu, X.-Y., Liu, Z.-M., Wang, X.-Z., Yang, Y.-Q. A novel NKX2-5 mutation in familial ventricular septal defect. Int. J. Molec. Med. 27: 369-375, 2011. [PubMed: 21165553, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 1/13/2012
carol : 10/30/2019
carol : 11/15/2017
carol : 01/20/2012
carol : 1/20/2012
carol : 1/18/2012

# 614431

VENTRICULAR SEPTAL DEFECT 2; VSD2


DO: 1657;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
6q24.1 Ventricular septal defect 2 614431 Autosomal dominant 3 CITED2 602937

TEXT

A number sign (#) is used with this entry because of evidence that ventricular septal defect-2 (VSD2) can be caused by heterozygous mutation in the CITED2 gene (602937) on chromosome 6q24.


Description

Ventricular septal defect (VSD) is the most common form of congenital cardiovascular anomaly, occurring in nearly 50% of all infants with a congenital heart defect and accounting for 14% to 16% of cardiac defects that require invasive treatment within the first year of life. Congenital VSDs may occur alone or in combination with other cardiac malformations. Large VSDs that go unrepaired may give rise to cardiac enlargement, congestive heart failure, pulmonary hypertension, Eisenmenger's syndrome, delayed fetal brain development, arrhythmias, and even sudden cardiac death (summary by Wang et al. (2011, 2011)).

For a discussion of genetic heterogeneity of ventricular septal defect, see VSD1 (614429).


Molecular Genetics

Sperling et al. (2005) screened a cohort of 392 patients with congenital heart defects for mutations in the CITED2 gene (602937) and identified a 27-bp deletion in a patient with a perimembranous ventricular septal defect. The mutation, which was not found in 192 controls, resulted in significant loss of HIF1A (603348) transcriptional repressive capacity and significantly diminished TFAP2C (601602) coactivation.


REFERENCES

  1. Sperling, S., Grimm, C. H., Dunkel, I., Mebus, S., Sperling, H.-P., Ebner, A., Galli, R., Lehrach, H., Fusch, C., Berger, F., Hammer, S. Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum. Mutat. 26: 575-582, 2005. [PubMed: 16287139] [Full Text: https://doi.org/10.1002/humu.20262]

  2. Wang, J., Fang, M., Liu, X.-Y., Xin, Y.-F., Liu, Z.-M., Chen, X.-Z., Wang, X.-Z., Fang, W.-Y., Liu, X., Yang, Y.-Q. A novel GATA4 mutation responsible for congenital ventricular septal defects. Int. J. Molec. Med.. 28: 557-564, 2011. [PubMed: 21637914] [Full Text: https://doi.org/10.3892/ijmm.2011.715]

  3. Wang, J., Xin, Y.-F., Liu, X.-Y., Liu, Z.-M., Wang, X.-Z., Yang, Y.-Q. A novel NKX2-5 mutation in familial ventricular septal defect. Int. J. Molec. Med. 27: 369-375, 2011. [PubMed: 21165553] [Full Text: https://doi.org/10.3892/ijmm.2010.585]


Creation Date:
Marla J. F. O'Neill : 1/13/2012

Edit History:
carol : 10/30/2019
carol : 11/15/2017
carol : 01/20/2012
carol : 1/20/2012
carol : 1/18/2012